Bio-Rad Laboratories Inc Class B

Financials

Panoramica Estratto Conto Statistiche Dividendi

Flusso di cassa derivante dalle attività operative 575.33 M656.52 M194.45 M374.94 M455.2 M532.2 M 532.2 M Flussi di cassa derivanti dalle attività di investimento -60.25 M-784.44 M-1.21 B20.21 M-160.2 M-189.7 M -189.7 M Liquidità derivante dalle attività di finanziamento -523.04 M-55.43 M973.58 M-425.65 M-218.8 M-283.2 M -283.2 M Liquidità libera 476.41 M535.72 M81.67 M218.26 M289.6 M374.6 M 374.6 M

Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets. The company was founded in 1952 in Berkeley, California, by husband and wife team David and Alice Schwartz, both graduates of the University of California, Berkeley. Bio-Rad is based in Hercules, California, and has operations worldwide.

BIO-B

Financials

Bio-Rad Laboratories Inc Class B

Notizie

Why Is Agilent (A) Down 6.2% Since Last Earnings Report?

International Markets and Bio-Rad (BIO): A Deep Dive for Investors

Bio-Rad's Q4 Earnings Miss Estimates, Revenues Surpass, Stock Down

Bio-Rad Laboratories, Inc. 2025 Q4 - Results - Earnings Call Presentation (NYSE:BIO) 2026-02-12

Bio-Rad Laboratories, Inc. (BIO) Q4 2025 Earnings Call Transcript

Bio-Rad: crescita modesta nel Q4 2025 tra divergenze di segmento e cambi strategici

Bio-Rad Q4 2025 slides reveal modest growth amid segment divergence and strategic shifts

Earnings call transcript: Bio-Rad Labs Q4 2025 misses EPS expectations

Bio-Rad Laboratories (BIO) Q4 Earnings Miss Estimates

Le azioni Bio-Rad crollano dopo risultati trimestrali sotto le attese

Bio-Rad shares tumble as Q4 earnings miss expectations

I risultati di Bio-Rad in arrivo mentre le stime calano prima del report